For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT06819007?term=GOG-3112&rank=1
GOG-3112: A Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan with Bevacizumab Versus Bevacizumab Monotherapy as First-line Maintenance Therapy in HER2-Expressing Ovarian Cancer (DS8201-772/ENGOT-ov89/GEICO144-O)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Gynecologic
Study Status:
Open to Accrual
Principal investigator:
Fong Liu, MD
IRB number :
2280060
Study Number:
G2502
Phone:
Fax:
GOG-3127: A Randomised, Open-label, Phase III Study of AZD5335 Versus Mirvetuximab Soravtansine in FRa-high and AZD5335 Versus Investigator’s Choice Chemotherapy in FRa-low Expressing High-grade Platinum-resistant Epithelial Ovarian Cancer Patients (TREVI-OC-01)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Gynecologic
Study Status:
Open to Accrual
Principal investigator:
Fong Liu, MD
IRB number :
2407503
Study Number:
G2512
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT07218809?term=trevi&viewType=Card&rank=2
GOG-3129: A Phase 2, Single-Arm Study of INCB123667 in Participants with Platinum-Resistant Ovarian Cancer with Cyclin E1 Overexpression (INCB123667-203)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Gynecologic
Study Status:
Open to Accrual
Principal investigator:
Kimberly Levinson, MD
IRB number :
2373720
Study Number:
G2509
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT07023627?term=GOG-3129&rank=1
GOLSEEK-4: A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator’s Choice in Participants with Relapsed/Refractory Follicular Lymphoma (CA073-1003)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Leukemia/Lymphoma/Myeloma
Study Status:
Open to Accrual
Principal investigator:
Zhuoyan Li, MD
IRB number :
2318429
Study Number:
G2504
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT06911502?term=golseek-4&limit=10&sort=@relevance&rank=1
KEVLARx: A Randomized Placebo-Controlled Trial of Two Schedules of RRx-001 for the Attenuation of Severe Oral Mucositis in Patients Receiving Concomitant Chemoradiation for the Treatment of Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx (Temporarily Closed to Accrual)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Head and Neck
Study Status:
Suspended
Principal investigator:
Geoffrey Neuner, MD
IRB number :
2124031
Study Number:
G2311
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05966194